We're live

Redirect to our partners sites

Joining forces to advance Time in Range

Join us here on 21 September at 19:00 CEST for a conversation between The diaTribe Foundation’s Kelly Close and Professor Thomas Danne as they discuss the opportunities and challenges of using Time in Range as part of diabetes management.

Watch the conversation between The diaTribe Foundation’s Kelly Close and Professor Thomas Danne as they discuss the opportunities and challenges of using Time in Range as part of diabetes management.

Watch the trailer now

Interested in Time in Range?

Sign up here to receive updates and new information about Time in Range.

Stay in Touch

Did you miss the talk?

It’s not too late to join the Time in Range conversation. Watch the full video or check out some of the highlights below to hear what Kelly Close and Professor Thomas Danne have to say about the benefits of time in range in diabetes management.
Speakers

Two prominent voices in diabetes share their views on Time in Range

Kelly Close

Kelly L. Close is the founder and Chair of the Board of the diaTribe Foundation, a non-profit organisation dedicated to advocating for and improving the lives of people living with diabetes and prediabetes.

Professor Thomas Danne

Professor Thomas Danne is the Director of the Department of General Paediatrics and Endocrinology/Diabetology at the Auf der Bult Hospital for Children and Adolescents, Hannover Medical School, the largest paediatric diabetes centre in Germany.

Time in range

What is Time in Range?

Time in Range is the amount of time you spend within your target glucose range each day. By continuously measuring your blood glucose levels, you can see how often you are in range and how often you are too high or too low. Guidelines recommend you spend at least 70% of your day in range. If you spend 18 hours a day in the recommended range, your Time in Range is 75% – and each 5% improvement means you get one more hour a day in range.

Learn more about Time in Range
Three organisations
One purpose

Diabetes care is a complex landscape of continuous innovation with new treatments and new devices. Each advancement helps make a meaningful difference in the lives of people with diabetes, yet significant unmet needs remain.

Novo Nordisk, Abbott and the diaTribe Foundation are all committed to improving the lives of people with diabetes, and we believe one of the most promising and important evolutions in the management of diabetes today is about something very simple, yet incredibly impactful. It’s about Time in Range.

Time in Range is a new approach to managing diabetes that can benefit both people with diabetes and their healthcare providers. More than a parameter for evaluating glucose levels, Time in Range uses valuable information to better inform the management of diabetes at an individual level. It provides actionable insights that can empower people living with diabetes to take better control of their health and their future. By helping us understand today, Time in Range is our tool for creating a brighter tomorrow.

Together we are joining forces to improve the lives of people living with diabetes by raising awareness and understanding of the importance of Time in Range as the emerging standard of care.

Redirect to our partners sites

Want to stay in touch?
We will soon launch new content to the website. Sign up here to receive information about Time in Range.
Stay in touch We will send a confirmation to your e-mail.
Opinions

Do you think Time in Range is an important clinical parameter to better manage diabetes?

On 17 September we posted a poll on Twitter asking whether you believe Time in Range can be considered an important clinical parameter in the management of diabetes.
Here’s the result.

Stay in touch
Sign up for more information
on Time in Range